2-Aminoethyl Dihydrogen Phosphate (2-AEH2P) Associated with Cell Metabolism-Modulating Drugs Presents a Synergistic and Pro-Apoptotic Effect in an In Vitro Model of the Ascitic Ehrlich Tumor
Open Access
- 4 January 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 109
Abstract
The progression and maintenance of cancer characteristics are associated with cellular components linked to the tumor and non-cellular components with pro-tumoral properties. Pharmacological association with antagonists of the cellular components of the tumor, such as anti- and pro-apoptotic drugs, represents a novel adjuvant strategy. In this study, the antiproliferative, pro-apoptotic, and pharmacological effects of the combination of monophosphoester 2-AEH2P with Simvastatin, Coenzyme Q10, the chemotherapeutic drug paclitaxel, and colony-stimulating factor (GM-CSF) were evaluated. Tests were conducted to determine cytotoxic activity using the MTT method, cell cycle phases, and fragmented DNA by flow cytometry, mitochondrial membrane potential, expression of cell markers Bcl2, TNF-α/DR-4, Cytochrome c, caspase 3, and P53, and analysis of drug combination profiles using Synergy Finder 2.0 Software. The results showed a synergistic effect among the combinations, compared to individual treatments with the monophosphoester and other drugs. In addition, there was modulation of marker expression, indicating a pro-apoptotic and immunomodulatory effect of 2-AEH2P. Pharmacological analysis revealed that tumor cells treated with GM-CSF + 2-AEH2P exhibited a synergistic effect, while groups of tumor cells treated with paclitaxel, Coenzyme Q10, and Simvastatin showed additive effects. Furthermore, treatment with the paclitaxel + 2-AEH2P combination (12 h) resulted in a significant reduction in mitochondrial membrane potential. Pharmacological combinations for normal cells did not exhibit deleterious effects compared to mammary carcinomatosis tumor (EAT) cells.Keywords
Funding Information
- Coordination for the Improvement of Higher Education Personnel—CAPES (88882.328116/2019-01, 305056/2019-0)
- National Council for Scientific and Technological Development—CNPq (88882.328116/2019-01, 305056/2019-0)
This publication has 63 references indexed in Scilit:
- Paclitaxel Induces Apoptosis in Breast Cancer Cells through Different Calcium—Regulating Mechanisms Depending on External Calcium ConditionsInternational Journal of Molecular Sciences, 2014
- Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathwayBiomedicine & Pharmacotherapy, 2013
- Mitochondria and cancerNature Reviews Cancer, 2012
- Results of the first phase 1 clinical trial of the HER‐2/neu peptide (GP2) vaccine in disease‐free breast cancer patientsCancer, 2009
- Recombinant interferon α-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-α and 5-year follow-upMelanoma Research, 2007
- Induction of Apoptosis by Cancer ChemotherapyExperimental Cell Research, 2000
- Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cellsJournal of Cancer Research and Clinical Oncology, 1997
- Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteinsFEBS Letters, 1995
- Interaction andin vivo growth inhibition of Ehrlich ascites tumor cells by jacalinJournal of Biosciences, 1988
- Übertragunsversuche mit carcinomatöser Mäuse-Ascitesflüssigkeit und ihr Verhalten gegen physikalische und chemische EinwirkungenJournal of Cancer Research and Clinical Oncology, 1932